Bio Economy 2.0 Roundtable Aims to Make Korea the Leading Biopharmaceutical Manufacturing Country
‘Bio Economy 2.0 Roundtable’ Aims to Propelling South Korea to the Forefront of Biopharmaceutical Manufacturing SEOUL – In a bid to establish itself as a global leader in biopharmaceutical manufacturing, South Korea hosted the ‘Bio Economy 2.0 Roundtable’ on the 19th. The event was attended by government officials, CEOs of major bio companies, and heads […]
Samsung BioLogics Signs $1.2 Trillion Contract Manufacturing Organization (CMO) Deal with Pfizer
Samsung BioLogics Signs a $897 Million CMO Contract with Pfizer, The Largest Deal in Company History Panoramic view of Samsung Biologics 3rd Plant / Photo = Samsung Bilogics Samsung BioLogics, a leading biopharmaceutical contract development and manufacturing company (CMDO), has captured the attention of the industry with a contract manufacturing organization (CMO) deal worth 1.2 […]
Samsung Biologics Publishes ESG Report 2022: Highlights Environmental, Social, and Governance Strategies
Samsung Biologics Publishes ESG Report Outlining Environmental, Social, and Governance Strategies In a recent announcement, Samsung Biologics, led by CEO John Lim, disclosed its ESG report for 2022, revealing key performance indicators and long-term strategies for environmental, social, and governance (ESG) management. This marks the third publication of the report this year and is particularly […]
